Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-09-18FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for simvastatin submitted by NorthStar Rx LLC under ANDA077691. This action pertains to the appr…
-
FDA approval · 2010-09-14FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for fenofibric acid from Amneal Pharmaceuticals of New York LLC. Fenofibric acid is a lipid-lowe…
-
FDA approval · 2010-09-14FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Welchol (colesevelam hydrochloride) filed by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2010-09-13FDA Approved: GEMFIBROZIL — Original Application (Northstar RxLLC)
FDA approved the original ANDA for gemfibrozil from Northstar RxLLC, providing a generic version of the lipid-lowering drug.
-
FDA approval · 2010-09-08FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for simvastatin submitted by NorthStar Rx LLC. The approval indicates an approved modification to th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-06-08Clinical Trial Update: Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients [Phase 4]
Phase 4 clinical trial evaluating rosuvastatin's effect on triglyceride levels in Mexican patients with hypertriglyceridemia; results have b…
-
FDA approval · 2010-06-01FDA Approved: LIVALO — Supplemental Application (Kowa Pharmaceuticals America, Inc.)
FDA approved a supplemental application for LIVALO (pitavastatin calcium) submitted by Kowa Pharmaceuticals America, Inc. The approval const…
-
CLINICAL_TRIALS research · 2010-05-27Clinical Trial Update: Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH) [Phase 4]
Phase 4 clinical trial update evaluating rosuvastatin in Chinese patients with hyperlipidemia and atherosclerosis.
-
CLINICAL_TRIALS research · 2010-05-05Clinical Trial Update: The Effect of Providing Free Samples of Generic Cardiovascular Medications to Physicians [NA]
This clinical trial update examines the impact of providing physicians with free samples of generic cardiovascular medications on hypertensi…
-
FDA approval · 2010-05-03FDA Approved: LOVASTATIN — Supplemental Application (Carlsbad Technology, Inc.)
FDA approved a supplemental application for Lovastatin submitted by Carlsbad Technology, Inc.
-
FDA approval · 2010-04-30FDA Approved: FENOFIBRATE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
FDA approved a supplemental application for fenofibrate from Rhodes Pharmaceuticals L.P., authorizing changes to the approved product under …
-
FDA label_change · 2010-04-22FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) from Organon LLC to update the product labeling.
-
CLINICAL_TRIALS trial_result · 2010-04-09Clinical Trial Update: Effects of Hypolipemic Treatment on Adipokines [NA]
Clinical trial evaluating the effects of lipid-lowering therapy on adipokine levels. The study has completed.
-
FDA approval · 2010-04-08FDA Approved: ZOCOR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for ZOCOR (simvastatin) submitted by Organon LLC. This action updates the product's labeling and…
-
FDA approval · 2010-03-10FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for VYTORIN (ezetimibe/simvastatin) submitted by Organon LLC.
-
FDA approval · 2010-02-17FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories to market a generic fixed-dose combination of amlodipine besylate and atorv…
-
CLINICAL_TRIALS research · 2010-02-15Clinical Trial Update: Improving Medication Adherence in Comorbid Conditions [NA]
This clinical trial update notes completion of an NIH-sponsored study aimed at improving medication adherence in individuals with Type 2 dia…
-
CLINICAL_TRIALS research · 2010-01-27Clinical Trial Update: U-CHAMP: Urban Cardiovascular Health Assessment and Management Program [NA]
This is a trial update for the U-CHAMP urban cardiovascular health assessment and management program. The sponsor is the University of Calga…
-
CLINICAL_TRIALS trial_result · 2010-01-12Clinical Trial Update: Use of Conjugated Linoleic Acid as a Nutraceutical for Weight Loss in Humans [Phase 1]
Phase 1 clinical trial update evaluating conjugated linoleic acid as a weight-loss nutraceutical; completed with measurements on body weight…
-
CLINICAL_TRIALS trial_result · 2010-01-12Clinical Trial Update: Lepticore in Metabolic Syndrome and Weight Loss [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating Lepticore for obesity, hyperlipidemia, hyperglycemia, and metabolic syndrome.
-
FDA approval · 2010-01-08FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for Pravastatin Sodium (generic pravastatin) under the ANDA, authoriz…
-
FDA approval · 2010-01-04FDA Approved: FENOFIBRATE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
FDA approved a supplemental application for fenofibrate from Rhodes Pharmaceuticals L.P. under the ANDA process.
-
FDA approval · 2009-11-06FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) from Organon LLC.
-
CLINICAL_TRIALS trial_result · 2009-11-05Clinical Trial Update: Effect of Plant Stanol Esters on Blood Lipids [NA]
A completed clinical trial evaluating the effect of plant stanol esters on blood lipid levels in individuals with elevated lipids.
-
CLINICAL_TRIALS trial_result · 2009-11-03Clinical Trial Update: Effect of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).
A completed clinical trial from AstraZeneca assessed the impact of patient education on cardiovascular risk factors in individuals with type…